Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum beta2-microglobulin in chronic hepatitis C

M Malaguarnera1, S Restuccia, I Di Fazio

  • 1Istituto di Medicina Interna e Geriatria, Medical School of Catania, Italy.

Digestive Diseases and Sciences
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive function modulation during aging: a focus on L-alpha-GPE.

European review for medical and pharmacological sciences·2021
Same author

Our experience with prurigo nodularis treated with dupilumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease.

La Clinica terapeutica·2019
Same author

Possible role of polycyclic aromatic hydrocarbons in the onset of melanoma: preliminary data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Serum beta2-microglobulin (beta2-MG) levels are elevated in chronic hepatitis C patients, correlating with disease severity and HCV RNA levels. This suggests increased beta2-MG production during liver disease progression.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • beta2-Microglobulin (beta2-MG) is integral to the main histocompatibility complex class I (MHC I) and influences immune responses.
  • Chronic hepatitis C virus (HCV) infection leads to significant liver damage and immune dysregulation.

Purpose of the Study:

  • To investigate serum beta2-MG levels in patients with chronic hepatitis C.
  • To correlate beta2-MG levels with disease duration, severity, and viral load.

Main Methods:

  • Serum beta2-MG levels were measured in chronic hepatitis C patients and healthy controls.
  • Statistical analyses were performed to compare groups and assess correlations.

Main Results:

  • Patients with chronic hepatitis C exhibited significantly higher serum beta2-MG levels compared to healthy controls (P = 0.0003).

Related Experiment Videos

  • Serum beta2-MG levels positively correlated with the duration and severity of hepatitis C.
  • A significant correlation was found between beta2-MG levels and HCV RNA levels, but not HCV genotypes.

    • Conclusions:

    • Elevated serum beta2-MG in chronic hepatitis C patients reflects disease progression.
    • The increase in beta2-MG is likely due to augmented production rather than impaired excretion.
    • beta2-MG may serve as a biomarker for monitoring hepatitis C progression.